Background: Acute pancreatitis (AP) is a common serious illness, and is characterized by rapid deterioration and a high mortality rate. Several biomarkers can evaluate and guide the treatment of acute pancreatitis, but there is currently no consensus on which markers are the most effective, simple, and economical for treating early-onset AP. In this study, we used the MIMIC III database to conduct a retrospective study on the relationship between early lactate/albumin (LAC/ALB), in-hospital mortality, and complication rates in patients with acute pancreatitis in the ICU.Methods: Basic data and indicators of laboratory tests, hospital deaths, and hospitalization days of acute pancreatitis patients were extracted from the database, after which the relationship between LAC/ALB and hospital mortality, ICU hospitalization days, and organ failure were evaluated using a t-test, a rank-sum test, a chi-square test or Fisher's exact probability method, and a Cox proportional hazard model.Results: 894 patients met the requirements and were selected from the MIMIC III database. They were subsequently grouped according to the lower limit ratio of the LAC/ALB normal value of 0.7. The group with LAC/ALB>0.7 showed higher hospital mortality rates, and the Lac, Inr, nitrogen, blood sugar, AKI incidence, Tbil, Sapsii score, and Sofa scores were all higher than the group with LAC/ALB<0.7. A multivariate Cox regression analysis model was used to explore the relationship between LAC/ALB levels and inpatient mortality. After including different adjustment variables, we determined that LAC/ALB is a risk factor for in-hospital death. The results of the subgroup analysis of LAC/ALB levels and mortality of hospitalized patients indicate that higher levels of LAC/ALB are risk factors for in-hospital deaths in patients with acute pancreatitis.